Tarbox Family Office’s Haemonetics HAE Stock Holding History

Tarbox Family Office’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-34	Closed	-$2K	–	490
2022 Q1	$2K	Hold	34	–	–	﹤0.01%	807
2021 Q4	$2K	Hold	34	–	–	﹤0.01%	879
2021 Q3	$2K	Hold	34	–	–	﹤0.01%	924
2021 Q2	$2K	Hold	34	–	–	﹤0.01%	933
2021 Q1	$4K	Hold	34	–	–	﹤0.01%	637
2020 Q4	$4K	Hold	34	–	–	﹤0.01%	590
2020 Q3	$3K	Hold	34	–	–	﹤0.01%	616
2020 Q2	$3K	Hold	34	–	–	﹤0.01%	621
2020 Q1	$3K	Hold	34	–	–	﹤0.01%	528
2019 Q4	$4K	Hold	34	–	–	﹤0.01%	556
2019 Q3	$4K	Hold	34	–	–	﹤0.01%	503
2019 Q2	$4K	Buy	+34	New	+$3.35K	﹤0.01%	500

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tarbox Family Office's HAE Position: Q2 2022 in Review

Tarbox Family Office sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 34 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in HAE in Q2 2019 and held it in 12 quarters. The position peaked at $4K in Q1 2021. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

Tarbox Family Office reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 34 Haemonetics shares in Q2 2022, an estimated $2K.
Tarbox Family Office first reported a position in Haemonetics in Q2 2019 and held it in 12 quarters.
Tarbox Family Office's Haemonetics position peaked at $4K in Q1 2021.
241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.